[1] |
ZHAO C G, LIU Z Y. MicroRNA 617 targeting SERPINE1 inhibited the progression of oral squamous cell carcinoma[J]. Mol Cell Biol, 2021, 41(6):e0056520. doi:10.1128/MCB.00565-20.
|
[2] |
YIN P, CUI S L, LIAO X L, et al. Galectin-3 blockade suppresses the growth of cetuximab-resistant human oral squamous cell carcinoma[J]. Mol Med Rep, 2021, 24(4):685. doi:10.3892/mmr.2021.12325.
|
[3] |
WU K, HAN N N, MAO Y, et al. Increased levels of PD1 and glycolysis in CD4+ T cells are positively associated with lymph node metastasis in OSCC[J]. BMC Oral Health, 2023, 23(1):356. doi:10.1186/s12903-023-03043-6.
|
[4] |
DIOGUARDI M, SPIRITO F, SOVERETO D, et al. MicroRNA-21 expression as a prognostic biomarker in oral cancer:systematic review and Meta-analysis[J]. Int J Environ Res Public Health, 2022, 19(6):3396. doi:10.3390/ijerph19063396.
|
[5] |
YANG J, WANG H, XU W, et al. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4[J]. Eur Rev Med Pharmacol Sci, 2020, 24(24):12717-12726. doi:10.26355/eurrev_202012_24170.
|
[6] |
KIM S, PARK S, OH J H, et al. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression[J]. BMC Oral Health, 2022, 22(1):378. doi:10.1186/s12903-022-02425-6.
|
[7] |
PARVAEE P, SARMADIAN H, KHANSRINEJAD B, et al. Plasma level of microRNAs,miR-107,miR-194 and miR-210 as potential biomarkers for diagnosis intestinal-type gastric cancer in human[J]. Asian Pac J Cancer Prev, 2019, 20(5):1421-1426. doi:10.31557/APJCP.
|
[8] |
CAI P, LI J J, CHEN G M, et al. MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1[J]. Oncol Lett, 2020, 19(3):1958-1966. doi:10.3892/ol.2020.11248.
|
[9] |
NA C, LI X, ZHANG J, et al. miR-107 targets TRIAP1 to regulate oral squamous cell carcinoma proliferation and migration[J]. Int J Clin Exp Pathol, 2019, 12(5):1820-1825.
|
[10] |
SHARMA A, NATARAJAN S, MANAKTALA N, et al. Prognostic nomogram for lymph-node metastasis in oral squamous cell carcinoma (OSCC) using immunohistochemical marker D2-40[J]. Cancer Manag Res, 2023, 15:929-936. doi:10.2147/CMAR.S408772.
|
[11] |
SHARMA P, KAUSHIK V, SARAYA A, et al. Aberrant expression of FGFRL1 in esophageal cancer and its regulation by miR-107[J]. Asian Pac J Cancer Prev, 2023, 24(4):1331-1341. doi:10.31557/APJCP.2023.24.4.1331.
|
[12] |
ZHANG P, ZHANG W, JIANG J, et al. MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3[J]. Gastrointest Oncol, 2022, 13(4):1541-1555. doi:10.21037/jgo-22-575.
|